TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

Marianna B. Ruzinova; Yi Shan Lee; Eric J. Duncavage; John S. Welch

doi:10.3324/haematol.2018.205302

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

Marianna B. Ruzinova, Yi Shan Lee, Eric J. Duncavage, John S. Welch

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e345-e348
Journal	Haematologica
Volume	104
Issue number	8
DOIs	https://doi.org/10.3324/haematol.2018.205302
State	Published - Jul 31 2019

Access to Document

10.3324/haematol.2018.205302

Cite this

@article{93d2ba612602404284f0731a348ae415,

title = "TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies",

author = "Ruzinova, {Marianna B.} and Lee, {Yi Shan} and Duncavage, {Eric J.} and Welch, {John S.}",

note = "Funding Information: The authors would like to thank Sharon Heath, Kierstin Luber, Megan Janke, Paige Schnoebelen, Theresa Fletcher, Megan Haney, and Shannon Kramer for assistance in patient enrollment, sample collection, and clinical data processing. We thank Greg Malnassy, Nichole Helton, and the Washington University Tissue Procurement Core for sample storage and sample preparation. Funding: support was provided by an NCI AML-SPORE (P50 CA171963) and the Genomics of AML Program Project grant (P01 CA101937). Funding Information: Funding: support was provided by an NCI AML-SPORE (P50 CA171963) and the Genomics of AML Program Project grant (P01 CA101937).",

year = "2019",

month = jul,

day = "31",

doi = "10.3324/haematol.2018.205302",

language = "English",

volume = "104",

pages = "e345--e348",

journal = "Haematologica",

issn = "0390-6078",

number = "8",

}

TY - JOUR

T1 - TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

AU - Ruzinova, Marianna B.

AU - Lee, Yi Shan

AU - Duncavage, Eric J.

AU - Welch, John S.

N1 - Funding Information: The authors would like to thank Sharon Heath, Kierstin Luber, Megan Janke, Paige Schnoebelen, Theresa Fletcher, Megan Haney, and Shannon Kramer for assistance in patient enrollment, sample collection, and clinical data processing. We thank Greg Malnassy, Nichole Helton, and the Washington University Tissue Procurement Core for sample storage and sample preparation. Funding: support was provided by an NCI AML-SPORE (P50 CA171963) and the Genomics of AML Program Project grant (P01 CA101937). Funding Information: Funding: support was provided by an NCI AML-SPORE (P50 CA171963) and the Genomics of AML Program Project grant (P01 CA101937).

PY - 2019/7/31

Y1 - 2019/7/31

UR - http://www.scopus.com/inward/record.url?scp=85066842306&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.205302

DO - 10.3324/haematol.2018.205302

M3 - Letter

C2 - 30792212

AN - SCOPUS:85066842306

SN - 0390-6078

VL - 104

SP - e345-e348

JO - Haematologica

JF - Haematologica

IS - 8

ER -

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

Access to Document

Other files and links

Cite this